Home » Stocks » NVIV

Invivo Therapeutics Holdings Corp. (NVIV)

Stock Price: $1.09 USD 0.18 (20.34%)
Updated Mar 5, 2021 4:00 PM EST - Market closed
After-hours: $1.07 -0.02 (-1.84%) Mar 5, 7:59 PM
Market Cap 37.26M
Revenue (ttm) n/a
Net Income (ttm) -9.07M
Shares Out 6.90M
EPS (ttm) -1.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 5
Last Price $1.09
Previous Close $0.91
Change ($) 0.18
Change (%) 20.34%
Day's Open 0.99
Day's Range 0.90 - 1.12
Day's Volume 4,814,049
52-Week Range 0.50 - 2.69

News

Hide News
Business Wire - 2 weeks ago

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the recent publication of a peer-reviewed manuscript in the Journal of Neurosurgery: Spine ...

Business Wire - 4 months ago

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the closing of its previously announced public offering of 18,750,000 shares of its common ...

Business Wire - 5 months ago

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp.

About NVIV

InVivo Therapeutics Holdings, a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. The company is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for the implantation at the site of injury within a spinal cord. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Industry
Biotechnology
CEO
Richard Toselli
Employees
6
Stock Exchange
NASDAQ
Ticker Symbol
NVIV
Full Company Profile

Financial Performance

Financial Statements